Phathom Pharmaceuticals, As Of December 31, 2023, Cash And Cash Equivalents Were $381.4M And An Additional $160M Available Under The Company's Term Loan With Hercules, Is Expected To Provide A Cash Runway Through The End Of 2026
Benzinga Newsdesk - Mar 7, 2024, 8:06AM